Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?
Verrica Pharmaceuticals Ownership Summary
Verrica Pharmaceuticals is owned by 62.80% institutional investors, 43.88% insiders. Armistice capital is the largest institutional shareholder, holding 19.06% of VRCA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.41% of its assets in Verrica Pharmaceuticals shares.
VRCA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Verrica Pharmaceuticals | 62.80% | 43.88% | -6.69% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Armistice capital | 8.92M | 19.06% | $6.24M |
| Caligan partners lp | 7.43M | 15.87% | $5.20M |
| Perceptive advisors | 3.25M | 6.94% | $2.27M |
| Boothbay fund management | 2.59M | 5.53% | $1.81M |
| Vanguard group | 1.88M | 4.02% | $1.32M |
| Blackrock funding, inc. /de | 1.19M | 2.54% | $832.69K |
| Blackrock | 1.13M | 2.43% | $8.23M |
| Geode capital management | 477.27K | 1.02% | $334.13K |
| State street | 451.78K | 0.97% | $3.29M |
| Heights capital management | 351.14K | 0.75% | $245.80K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 7.43M | 1.32% | $5.20M |
| Heights capital management | 351.14K | 0.12% | $245.80K |
| Armistice capital | 8.92M | 0.09% | $6.24M |
| Bml capital management | 174.65K | 0.08% | $122.26K |
| Perceptive advisors | 3.25M | 0.06% | $2.27M |
| Boothbay fund management | 2.59M | 0.04% | $1.81M |
| Ground swell capital | 10.53K | 0.01% | $7.37K |
| Xtx topco | 48.08K | 0.00% | $33.66K |
| Steel peak wealth management | 76.00K | 0.00% | $53.20K |
| Spc financial | 30.00K | 0.00% | $21.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 8.92M | 0.09% | 8.92M |
| Caligan partners lp | 7.43M | 1.32% | 7.43M |
| Boothbay fund management | 2.59M | 0.04% | 2.59M |
| Vanguard group | 1.88M | - | 593.31K |
| Heights capital management | 351.14K | 0.12% | 351.14K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -4.00M |
| Perceptive advisors | 3.25M | 0.06% | -3.85M |
| Fmr | 14.67K | - | -619.64K |
| Propel bio management | - | - | -344.94K |
| Qube research | 35.26K | - | -286.92K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Armistice capital | 8.92M | 0.09% | 8.92M | $6.24M |
| Caligan partners lp | 7.43M | 1.32% | 7.43M | $5.20M |
| Boothbay fund management | 2.59M | 0.04% | 2.59M | $1.81M |
| Heights capital management | 351.14K | 0.12% | 351.14K | $245.80K |
| Pfg investments | 27.84K | 0.00% | 27.84K | $19.49K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Farther finance advisors | -31.00 |
| Quadrant capital group | -110.00 |
| Parallel advisors | -176.00 |
| Srs capital advisors | -241.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 77 | -3.75% | 29,394,921 | 97.36% | 62 | 6.20% | 39 | -9.30% | 18 | 12.50% |
| Sep 30, 2024 | 79 | 5.33% | 14,834,226 | -20.43% | 31 | 1.97% | 42 | 7.69% | 16 | - |
| Jun 30, 2024 | 74 | 21.31% | 18,643,941 | 5.04% | 40 | 2.62% | 38 | 111.11% | 16 | -20.00% |
| Mar 31, 2024 | 61 | -7.58% | 17,749,027 | -1.42% | 39 | 2.56% | 18 | -41.94% | 20 | 17.65% |
| Dec 31, 2023 | 66 | -4.35% | 18,004,540 | 19.63% | 39 | 3.64% | 31 | 6.90% | 17 | -10.53% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.30M | 1.41% | - |
| Invesco Dorsey Wright SmallCap Momt ETF | 409.00K | 0.96% | - |
| Vanguard US Total Market Shares ETF | 815.89K | 0.89% | - |
| iShares Russell 2000 ETF | 551.49K | 0.60% | -4.79K |
| Fidelity Select Biotechnology | 517.63K | 0.57% | -112.24K |
| Simplify Propel Opportunities ETF | 200.00K | 0.44% | - |
| DWS Small Cap Core S | 174.70K | 0.41% | - |
| Small Cap Core Equity Composite | 174.70K | 0.41% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 289.25K | 0.32% | - |
| Fidelity Small Cap Index | 209.10K | 0.23% | -3.92K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 17, 2025 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | $2.80K |
| Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $187.50K |
| Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $150.00K |
| Nov 22, 2024 | Rieger Jayson | CEO and President | Buy | $250.00K |
| Nov 22, 2024 | Stalfort John A III | - | Buy | $1000.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 1 |
| 2024 Q4 | 12 | - |
| 2024 Q3 | - | 18 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
VRCA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools